SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3ecn'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DMY_A_AZMA400_1 (MURINE CARBONIC ANHYDRASE V)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	5 / 11	HIS A 596 HIS A 560 LEU A 514 LEU A 565 THR A 568	ZN A 1 (-3.5A) ZN A 1 (-3.4A) None None None	1.19A	1dmyA-3ecnA: undetectable	1dmyA-3ecnA: 19.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EI6_D_PPFD412_1 (PHOSPHONOACETATE HYDROLASE)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 8	THR A 668 ASP A 597 HIS A 556 HIS A 560	MG A 2 ( 4.7A) MG A 2 ( 2.8A) None ZN A 1 (-3.4A)	1.02A	1ei6D-3ecnA: undetectable	1ei6D-3ecnA: 21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ITU_B_CILB452_1 (RENAL DIPEPTIDASE)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	5 / 12	ASP A 482 GLU A 535 TYR A 516 VAL A 484 PRO A 485	None	1.17A	1ituB-3ecnA: undetectable	1ituB-3ecnA: 20.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JTV_A_TESA500_1 (17 BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 8	VAL A 665 HIS A 560 SER A 561 VAL A 564	None ZN A 1 (-3.4A) None None	0.93A	1jtvA-3ecnA: undetectable	1jtvA-3ecnA: 22.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JTV_A_TESA500_1 (17 BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 8	VAL A 665 TYR A 549 SER A 561 VAL A 564	None	1.06A	1jtvA-3ecnA: undetectable	1jtvA-3ecnA: 22.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UDT_A_VIAA1000_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	5 / 12	TYR A 555 HIS A 556 ALA A 742 GLN A 778 PHE A 781	None None None IBM A 3 (-3.4A) IBM A 3 (-3.5A)	1.25A	1udtA-3ecnA: 35.2	1udtA-3ecnA: 26.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_C_CHDC3525_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE III)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.30A	1v54A-3ecnA: undetectable 1v54C-3ecnA: undetectable	1v54A-3ecnA: 18.32 1v54C-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_P_CHDP4525_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE III)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.33A	1v54N-3ecnA: undetectable 1v54P-3ecnA: undetectable	1v54N-3ecnA: 18.32 1v54P-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V55_C_CHDC3525_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE III)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.31A	1v55A-3ecnA: undetectable 1v55C-3ecnA: undetectable	1v55A-3ecnA: 18.32 1v55C-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WOP_A_FFOA2887_1 (AMINOMETHYLTRANSFERA SE)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	3 / 3	ASP A 801 GLU A 575 ARG A 524	None	0.66A	1wopA-3ecnA: undetectable	1wopA-3ecnA: 22.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XLX_A_CIOA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	9 / 12	TYR A 555 HIS A 556 HIS A 600 MET A 670 ASN A 729 ILE A 744 SER A 777 GLN A 778 PHE A 781	None None None IBM A 3 (-4.5A) None IBM A 3 (-4.3A) None IBM A 3 (-3.4A) IBM A 3 (-3.5A)	0.42A	1xlxA-3ecnA: 44.7	1xlxA-3ecnA: 34.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XLX_B_CIOB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	5 / 12	HIS A 556 HIS A 600 ILE A 744 SER A 777 PHE A 781	None None IBM A 3 (-4.3A) None IBM A 3 (-3.5A)	0.69A	1xlxB-3ecnA: 44.9	1xlxB-3ecnA: 34.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XLX_B_CIOB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	7 / 12	TYR A 555 HIS A 556 HIS A 600 MET A 670 ILE A 744 GLN A 778 PHE A 781	None None None IBM A 3 (-4.5A) IBM A 3 (-4.3A) IBM A 3 (-3.4A) IBM A 3 (-3.5A)	0.33A	1xlxB-3ecnA: 44.9	1xlxB-3ecnA: 34.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XMU_A_ROFA101_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	8 / 12	TYR A 555 HIS A 556 ASP A 726 PRO A 730 TRP A 740 ILE A 744 SER A 777 PHE A 781	None None ZN A 1 (-2.6A) None None IBM A 3 (-4.3A) None IBM A 3 (-3.5A)	0.37A	1xmuA-3ecnA: 44.6	1xmuA-3ecnA: 34.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XMU_B_ROFB102_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	8 / 12	TYR A 555 HIS A 556 MET A 670 ASP A 726 PRO A 730 TRP A 740 ILE A 744 SER A 777	None None IBM A 3 (-4.5A) ZN A 1 (-2.6A) None None IBM A 3 (-4.3A) None	0.38A	1xmuB-3ecnA: 44.7	1xmuB-3ecnA: 34.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOM_A_CIOA603_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	8 / 12	TYR A 555 HIS A 556 MET A 670 ASP A 726 ILE A 744 SER A 777 GLN A 778 PHE A 781	None None IBM A 3 (-4.5A) ZN A 1 (-2.6A) IBM A 3 (-4.3A) None IBM A 3 (-3.4A) IBM A 3 (-3.5A)	0.37A	1xomA-3ecnA: 44.8	1xomA-3ecnA: 33.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOM_B_CIOB601_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	7 / 12	TYR A 555 HIS A 556 MET A 670 ILE A 744 SER A 777 GLN A 778 PHE A 781	None None IBM A 3 (-4.5A) IBM A 3 (-4.3A) None IBM A 3 (-3.4A) IBM A 3 (-3.5A)	0.41A	1xomB-3ecnA: 45.0	1xomB-3ecnA: 33.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOQ_A_ROFA502_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	5 / 12	MET A 670 ASP A 726 PRO A 730 SER A 780 PHE A 781	IBM A 3 (-4.5A) ZN A 1 (-2.6A) None None IBM A 3 (-3.5A)	1.12A	1xoqA-3ecnA: 44.9	1xoqA-3ecnA: 33.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOQ_A_ROFA502_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	8 / 12	TYR A 555 HIS A 556 MET A 670 ASP A 726 PRO A 730 ILE A 744 SER A 777 PHE A 781	None None IBM A 3 (-4.5A) ZN A 1 (-2.6A) None IBM A 3 (-4.3A) None IBM A 3 (-3.5A)	0.41A	1xoqA-3ecnA: 44.9	1xoqA-3ecnA: 33.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOQ_A_ROFA502_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	3 / 3	ASN A 729 TRP A 740 GLN A 778	None None IBM A 3 (-3.4A)	0.16A	1xoqA-3ecnA: 44.9	1xoqA-3ecnA: 33.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOQ_B_ROFB501_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	8 / 12	TYR A 555 HIS A 556 ASP A 726 PRO A 730 TRP A 740 ILE A 744 SER A 777 PHE A 781	None None ZN A 1 (-2.6A) None None IBM A 3 (-4.3A) None IBM A 3 (-3.5A)	0.37A	1xoqB-3ecnA: 45.0	1xoqB-3ecnA: 33.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOQ_B_ROFB501_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	3 / 3	MET A 670 ASN A 729 GLN A 778	IBM A 3 (-4.5A) None IBM A 3 (-3.4A)	0.34A	1xoqB-3ecnA: 45.0	1xoqB-3ecnA: 33.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOS_A_VIAA1_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	6 / 12	TYR A 555 HIS A 556 MET A 670 ASP A 726 GLN A 778 PHE A 781	None None IBM A 3 (-4.5A) ZN A 1 (-2.6A) IBM A 3 (-3.4A) IBM A 3 (-3.5A)	0.44A	1xosA-3ecnA: 44.8	1xosA-3ecnA: 34.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOT_A_VDNA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	6 / 12	TYR A 555 HIS A 556 ILE A 744 GLN A 778 PHE A 781 ILE A 786	None None IBM A 3 (-4.3A) IBM A 3 (-3.4A) IBM A 3 (-3.5A) None	1.31A	1xotA-3ecnA: 44.8	1xotA-3ecnA: 34.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOT_A_VDNA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	7 / 12	TYR A 555 HIS A 556 MET A 670 ILE A 744 SER A 777 GLN A 778 PHE A 781	None None IBM A 3 (-4.5A) IBM A 3 (-4.3A) None IBM A 3 (-3.4A) IBM A 3 (-3.5A)	0.57A	1xotA-3ecnA: 44.8	1xotA-3ecnA: 34.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOT_B_VDNB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	6 / 12	TYR A 555 HIS A 556 ASN A 729 ILE A 744 SER A 777 PHE A 781	None None None IBM A 3 (-4.3A) None IBM A 3 (-3.5A)	0.60A	1xotB-3ecnA: 44.7	1xotB-3ecnA: 34.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOT_B_VDNB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	7 / 12	TYR A 555 HIS A 556 MET A 670 ASN A 729 ILE A 744 GLN A 778 PHE A 781	None None IBM A 3 (-4.5A) None IBM A 3 (-4.3A) IBM A 3 (-3.4A) IBM A 3 (-3.5A)	0.40A	1xotB-3ecnA: 44.7	1xotB-3ecnA: 34.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.30A	2dyrA-3ecnA: undetectable 2dyrC-3ecnA: undetectable	2dyrA-3ecnA: 18.32 2dyrC-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.32A	2dyrN-3ecnA: undetectable 2dyrP-3ecnA: undetectable	2dyrN-3ecnA: 18.32 2dyrP-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYS_C_CHDC304_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 6	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.29A	2dysA-3ecnA: undetectable 2dysC-3ecnA: undetectable	2dysA-3ecnA: 18.32 2dysC-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYS_P_CHDP304_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 6	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.29A	2dysN-3ecnA: undetectable 2dysP-3ecnA: undetectable	2dysN-3ecnA: 18.32 2dysP-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIJ_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.31A	2eijA-3ecnA: undetectable 2eijC-3ecnA: undetectable	2eijA-3ecnA: 18.32 2eijC-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIJ_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.32A	2eijN-3ecnA: undetectable 2eijP-3ecnA: undetectable	2eijN-3ecnA: 18.32 2eijP-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.32A	2eikA-3ecnA: undetectable 2eikC-3ecnA: undetectable	2eikA-3ecnA: 18.32 2eikC-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.34A	2eikN-3ecnA: undetectable 2eikP-3ecnA: undetectable	2eikN-3ecnA: 18.32 2eikP-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIL_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.31A	2eilA-3ecnA: undetectable 2eilC-3ecnA: undetectable	2eilA-3ecnA: 18.32 2eilC-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIL_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.32A	2eilN-3ecnA: undetectable 2eilP-3ecnA: undetectable	2eilN-3ecnA: 18.32 2eilP-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIM_A_CHDA525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 6	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.30A	2eimA-3ecnA: undetectable 2eimC-3ecnA: undetectable	2eimA-3ecnA: 18.32 2eimC-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIM_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 6	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.30A	2eimN-3ecnA: undetectable 2eimP-3ecnA: undetectable	2eimN-3ecnA: 18.32 2eimP-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIN_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 6	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.30A	2einA-3ecnA: undetectable 2einC-3ecnA: undetectable	2einA-3ecnA: 18.32 2einC-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIN_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 6	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.36A	2einN-3ecnA: undetectable 2einP-3ecnA: undetectable	2einN-3ecnA: 18.32 2einP-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_A_VIAA901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	5 / 11	TYR A 555 HIS A 556 ILE A 774 GLN A 778 PHE A 781	None None None IBM A 3 (-3.4A) IBM A 3 (-3.5A)	0.37A	2h42A-3ecnA: 35.0	2h42A-3ecnA: 25.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_B_VIAB902_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	5 / 12	TYR A 555 HIS A 556 ILE A 774 GLN A 778 PHE A 781	None None None IBM A 3 (-3.4A) IBM A 3 (-3.5A)	0.46A	2h42B-3ecnA: 34.8	2h42B-3ecnA: 25.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEY_A_EV1A1771_1 (CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	6 / 12	TYR A 555 HIS A 556 ILE A 744 GLU A 747 GLN A 778 PHE A 781	None None IBM A 3 (-4.3A) None IBM A 3 (-3.4A) IBM A 3 (-3.5A)	0.92A	2weyA-3ecnA: 36.5	2weyA-3ecnA: 24.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y69_A_CHDA1517_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.31A	2y69A-3ecnA: undetectable 2y69C-3ecnA: undetectable	2y69A-3ecnA: 18.32 2y69C-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZXW_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 6	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.33A	2zxwA-3ecnA: undetectable 2zxwC-3ecnA: undetectable	2zxwA-3ecnA: 18.32 2zxwC-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZXW_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 6	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.32A	2zxwN-3ecnA: undetectable 2zxwP-3ecnA: undetectable	2zxwN-3ecnA: 18.32 2zxwP-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABK_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.33A	3abkA-3ecnA: undetectable 3abkC-3ecnA: undetectable	3abkA-3ecnA: 18.32 3abkC-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABK_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.31A	3abkN-3ecnA: undetectable 3abkP-3ecnA: undetectable	3abkN-3ecnA: 18.32 3abkP-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABM_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.30A	3abmN-3ecnA: undetectable 3abmP-3ecnA: undetectable	3abmN-3ecnA: 18.32 3abmP-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG1_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 6	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.36A	3ag1A-3ecnA: 0.9 3ag1C-3ecnA: undetectable	3ag1A-3ecnA: 18.32 3ag1C-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG1_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 6	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.34A	3ag1N-3ecnA: undetectable 3ag1P-3ecnA: undetectable	3ag1N-3ecnA: 18.32 3ag1P-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG2_A_CHDA525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.33A	3ag2A-3ecnA: undetectable 3ag2C-3ecnA: undetectable	3ag2A-3ecnA: 18.32 3ag2C-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG2_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.34A	3ag2N-3ecnA: undetectable 3ag2P-3ecnA: undetectable	3ag2N-3ecnA: 18.32 3ag2P-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG3_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.31A	3ag3A-3ecnA: undetectable 3ag3C-3ecnA: undetectable	3ag3A-3ecnA: 18.32 3ag3C-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG3_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.32A	3ag3N-3ecnA: undetectable 3ag3P-3ecnA: undetectable	3ag3N-3ecnA: 18.32 3ag3P-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG4_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.33A	3ag4A-3ecnA: undetectable 3ag4C-3ecnA: undetectable	3ag4A-3ecnA: 18.32 3ag4C-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG4_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.33A	3ag4N-3ecnA: undetectable 3ag4P-3ecnA: undetectable	3ag4N-3ecnA: 18.32 3ag4P-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASN_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 6	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.32A	3asnA-3ecnA: undetectable 3asnC-3ecnA: undetectable	3asnA-3ecnA: 18.32 3asnC-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B2R_A_VDNA1_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	5 / 12	TYR A 555 HIS A 556 ILE A 774 GLN A 778 PHE A 781	None None None IBM A 3 (-3.4A) IBM A 3 (-3.5A)	0.58A	3b2rA-3ecnA: 30.5	3b2rA-3ecnA: 25.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B2R_B_VDNB1_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	5 / 11	TYR A 555 HIS A 556 ILE A 774 GLN A 778 PHE A 781	None None None IBM A 3 (-3.4A) IBM A 3 (-3.5A)	0.55A	3b2rB-3ecnA: 30.7	3b2rB-3ecnA: 25.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_A_ROFA901_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	5 / 12	MET A 670 ASN A 729 PRO A 730 SER A 780 PHE A 781	IBM A 3 (-4.5A) None None None IBM A 3 (-3.5A)	1.01A	3g4lA-3ecnA: 44.8	3g4lA-3ecnA: 32.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_A_ROFA901_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	9 / 12	TYR A 555 HIS A 556 MET A 670 ASN A 729 PRO A 730 TRP A 740 ILE A 744 SER A 777 PHE A 781	None None IBM A 3 (-4.5A) None None None IBM A 3 (-4.3A) None IBM A 3 (-3.5A)	0.43A	3g4lA-3ecnA: 44.8	3g4lA-3ecnA: 32.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_B_ROFB902_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	8 / 12	TYR A 555 HIS A 556 MET A 670 ASP A 726 PRO A 730 TRP A 740 ILE A 744 PHE A 781	None None IBM A 3 (-4.5A) ZN A 1 (-2.6A) None None IBM A 3 (-4.3A) IBM A 3 (-3.5A)	0.33A	3g4lB-3ecnA: 44.8	3g4lB-3ecnA: 32.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_C_ROFC903_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	8 / 12	TYR A 555 HIS A 556 MET A 670 ASP A 726 ASN A 729 PRO A 730 TRP A 740 ILE A 744	None None IBM A 3 (-4.5A) ZN A 1 (-2.6A) None None None IBM A 3 (-4.3A)	0.31A	3g4lC-3ecnA: 44.8	3g4lC-3ecnA: 32.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_C_ROFC903_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	3 / 3	SER A 777 GLN A 778 PHE A 781	None IBM A 3 (-3.4A) IBM A 3 (-3.5A)	0.22A	3g4lC-3ecnA: 44.8	3g4lC-3ecnA: 32.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_D_ROFD904_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	9 / 12	TYR A 555 HIS A 556 MET A 670 ASP A 726 PRO A 730 TRP A 740 ILE A 744 SER A 777 GLN A 778	None None IBM A 3 (-4.5A) ZN A 1 (-2.6A) None None IBM A 3 (-4.3A) None IBM A 3 (-3.4A)	0.41A	3g4lD-3ecnA: 44.7	3g4lD-3ecnA: 32.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IAK_A_EV1A415_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	5 / 9	TYR A 555 ILE A 744 GLN A 778 PHE A 781 ILE A 786	None IBM A 3 (-4.3A) IBM A 3 (-3.4A) IBM A 3 (-3.5A) None	1.45A	3iakA-3ecnA: 43.0	3iakA-3ecnA: 33.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IAK_A_EV1A415_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	6 / 9	TYR A 555 MET A 670 ASN A 729 ILE A 744 GLN A 778 PHE A 781	None IBM A 3 (-4.5A) None IBM A 3 (-4.3A) IBM A 3 (-3.4A) IBM A 3 (-3.5A)	0.53A	3iakA-3ecnA: 43.0	3iakA-3ecnA: 33.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JWQ_C_VIAC901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	TYR A 555 HIS A 556 GLN A 778 PHE A 781	None None IBM A 3 (-3.4A) IBM A 3 (-3.5A)	0.43A	3jwqC-3ecnA: 37.9	3jwqC-3ecnA: 26.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TVX_A_PNXA902_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	6 / 9	TYR A 555 ASN A 729 PRO A 730 ILE A 744 GLN A 778 PHE A 781	None None None IBM A 3 (-4.3A) IBM A 3 (-3.4A) IBM A 3 (-3.5A)	0.36A	3tvxA-3ecnA: 44.3	3tvxA-3ecnA: 34.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TVX_B_PNXB902_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	5 / 7	TYR A 555 ASN A 729 ILE A 744 GLN A 778 PHE A 781	None None IBM A 3 (-4.3A) IBM A 3 (-3.4A) IBM A 3 (-3.5A)	0.38A	3tvxB-3ecnA: 44.5	3tvxB-3ecnA: 34.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UDA_A_DEXA1985_2 (MINERALOCORTICOID RECEPTOR)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 6	LEU A 716 TRP A 793 LEU A 688 THR A 580	None	0.85A	4udaA-3ecnA: 1.6	4udaA-3ecnA: 21.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1A_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.34A	5b1aN-3ecnA: undetectable 5b1aP-3ecnA: undetectable	5b1aN-3ecnA: 18.32 5b1aP-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1B_C_CHDC307_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 8	ASP A 621 TYR A 619 HIS A 676 LEU A 608	None	1.19A	5b1bA-3ecnA: undetectable 5b1bC-3ecnA: undetectable 5b1bP-3ecnA: undetectable	5b1bA-3ecnA: 18.32 5b1bC-3ecnA: 21.49 5b1bP-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1B_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.34A	5b1bN-3ecnA: undetectable 5b1bP-3ecnA: undetectable	5b1bN-3ecnA: 18.32 5b1bP-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B3S_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.37A	5b3sN-3ecnA: undetectable 5b3sP-3ecnA: undetectable	5b3sN-3ecnA: 18.32 5b3sP-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IY5_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.36A	5iy5A-3ecnA: undetectable 5iy5C-3ecnA: undetectable	5iy5A-3ecnA: 18.32 5iy5C-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TZO_A_7V7A202_1 (ENDO-1,4-BETA-XYLANA SE A)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	5 / 12	SER A 561 ALA A 592 PRO A 513 TRP A 541 ALA A 593	None	1.38A	5tzoA-3ecnA: undetectable	5tzoA-3ecnA: 18.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TZO_C_7V7C201_1 (ENDO-1,4-BETA-XYLANA SE A)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	5 / 12	SER A 561 ALA A 592 PRO A 513 TRP A 541 ALA A 593	None	1.37A	5tzoC-3ecnA: undetectable	5tzoC-3ecnA: 18.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X19_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 6	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.36A	5x19N-3ecnA: undetectable 5x19P-3ecnA: undetectable	5x19N-3ecnA: 18.32 5x19P-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X1B_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 6	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.36A	5x1bN-3ecnA: undetectable 5x1bP-3ecnA: undetectable	5x1bN-3ecnA: 18.32 5x1bP-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X1F_P_CHDP305_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.41A	5x1fN-3ecnA: undetectable 5x1fP-3ecnA: 1.6	5x1fN-3ecnA: 18.32 5x1fP-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCQ_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.36A	5zcqN-3ecnA: undetectable 5zcqP-3ecnA: undetectable	5zcqN-3ecnA: 18.32 5zcqP-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NKN_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 6	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.33A	6nknA-3ecnA: undetectable 6nknC-3ecnA: undetectable	6nknA-3ecnA: 18.32 6nknC-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMP_C_CHDC303_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 6	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.38A	6nmpA-3ecnA: 0.7 6nmpC-3ecnA: undetectable	6nmpA-3ecnA: 18.32 6nmpC-3ecnA: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMP_P_CHDP302_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	3ecn	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	4 / 7	ASP A 621 THR A 622 TYR A 619 HIS A 676	None	1.39A	6nmpN-3ecnA: undetectable 6nmpP-3ecnA: undetectable	6nmpN-3ecnA: 18.32 6nmpP-3ecnA: 21.49

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1DMY_A_AZMA400_1","MURINE CARBONIC ANHYDRASE V","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",5,"HIS A 596;HIS A 560;LEU A 514;LEU A 565;THR A 568"," ZN A   1 (-3.5A); ZN A   1 (-3.4A);None;None;None","1.19A","1dmyA-3ecnA:undetectable","1dmyA-3ecnA:19.65"],["1EI6_D_PPFD412_1","PHOSPHONOACETATE HYDROLASE","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"THR A 668;ASP A 597;HIS A 556;HIS A 560"," MG A   2 ( 4.7A); MG A   2 ( 2.8A);None; ZN A   1 (-3.4A)","1.02A","1ei6D-3ecnA:undetectable","1ei6D-3ecnA:21.20"],["1ITU_B_CILB452_1","RENAL DIPEPTIDASE","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",5,"ASP A 482;GLU A 535;TYR A 516;VAL A 484;PRO A 485","None","1.17A","1ituB-3ecnA:undetectable","1ituB-3ecnA:20.46"],["1JTV_A_TESA500_1","17 BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"VAL A 665;HIS A 560;SER A 561;VAL A 564","None; ZN A   1 (-3.4A);None;None","0.93A","1jtvA-3ecnA:undetectable","1jtvA-3ecnA:22.10"],["1JTV_A_TESA500_1","17 BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"VAL A 665;TYR A 549;SER A 561;VAL A 564","None","1.06A","1jtvA-3ecnA:undetectable","1jtvA-3ecnA:22.10"],["1UDT_A_VIAA1000_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",5,"TYR A 555;HIS A 556;ALA A 742;GLN A 778;PHE A 781","None;None;None;IBM A   3 (-3.4A);IBM A   3 (-3.5A)","1.25A","1udtA-3ecnA:35.2","1udtA-3ecnA:26.26"],["1V54_C_CHDC3525_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE III","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.30A","1v54A-3ecnA:undetectable;1v54C-3ecnA:undetectable","1v54A-3ecnA:18.32;1v54C-3ecnA:21.49"],["1V54_P_CHDP4525_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE III","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.33A","1v54N-3ecnA:undetectable;1v54P-3ecnA:undetectable","1v54N-3ecnA:18.32;1v54P-3ecnA:21.49"],["1V55_C_CHDC3525_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE III","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.31A","1v55A-3ecnA:undetectable;1v55C-3ecnA:undetectable","1v55A-3ecnA:18.32;1v55C-3ecnA:21.49"],["1WOP_A_FFOA2887_1","AMINOMETHYLTRANSFERASE","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",3,"ASP A 801;GLU A 575;ARG A 524","None","0.66A","1wopA-3ecnA:undetectable","1wopA-3ecnA:22.00"],["1XLX_A_CIOA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",9,"TYR A 555;HIS A 556;HIS A 600;MET A 670;ASN A 729;ILE A 744;SER A 777;GLN A 778;PHE A 781","None;None;None;IBM A   3 (-4.5A);None;IBM A   3 (-4.3A);None;IBM A   3 (-3.4A);IBM A   3 (-3.5A)","0.42A","1xlxA-3ecnA:44.7","1xlxA-3ecnA:34.16"],["1XLX_B_CIOB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",5,"HIS A 556;HIS A 600;ILE A 744;SER A 777;PHE A 781","None;None;IBM A   3 (-4.3A);None;IBM A   3 (-3.5A)","0.69A","1xlxB-3ecnA:44.9","1xlxB-3ecnA:34.16"],["1XLX_B_CIOB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",7,"TYR A 555;HIS A 556;HIS A 600;MET A 670;ILE A 744;GLN A 778;PHE A 781","None;None;None;IBM A   3 (-4.5A);IBM A   3 (-4.3A);IBM A   3 (-3.4A);IBM A   3 (-3.5A)","0.33A","1xlxB-3ecnA:44.9","1xlxB-3ecnA:34.16"],["1XMU_A_ROFA101_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",8,"TYR A 555;HIS A 556;ASP A 726;PRO A 730;TRP A 740;ILE A 744;SER A 777;PHE A 781","None;None; ZN A   1 (-2.6A);None;None;IBM A   3 (-4.3A);None;IBM A   3 (-3.5A)","0.37A","1xmuA-3ecnA:44.6","1xmuA-3ecnA:34.16"],["1XMU_B_ROFB102_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",8,"TYR A 555;HIS A 556;MET A 670;ASP A 726;PRO A 730;TRP A 740;ILE A 744;SER A 777","None;None;IBM A   3 (-4.5A); ZN A   1 (-2.6A);None;None;IBM A   3 (-4.3A);None","0.38A","1xmuB-3ecnA:44.7","1xmuB-3ecnA:34.16"],["1XOM_A_CIOA603_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",8,"TYR A 555;HIS A 556;MET A 670;ASP A 726;ILE A 744;SER A 777;GLN A 778;PHE A 781","None;None;IBM A   3 (-4.5A); ZN A   1 (-2.6A);IBM A   3 (-4.3A);None;IBM A   3 (-3.4A);IBM A   3 (-3.5A)","0.37A","1xomA-3ecnA:44.8","1xomA-3ecnA:33.42"],["1XOM_B_CIOB601_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",7,"TYR A 555;HIS A 556;MET A 670;ILE A 744;SER A 777;GLN A 778;PHE A 781","None;None;IBM A   3 (-4.5A);IBM A   3 (-4.3A);None;IBM A   3 (-3.4A);IBM A   3 (-3.5A)","0.41A","1xomB-3ecnA:45.0","1xomB-3ecnA:33.42"],["1XOQ_A_ROFA502_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",5,"MET A 670;ASP A 726;PRO A 730;SER A 780;PHE A 781","IBM A   3 (-4.5A); ZN A   1 (-2.6A);None;None;IBM A   3 (-3.5A)","1.12A","1xoqA-3ecnA:44.9","1xoqA-3ecnA:33.42"],["1XOQ_A_ROFA502_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",8,"TYR A 555;HIS A 556;MET A 670;ASP A 726;PRO A 730;ILE A 744;SER A 777;PHE A 781","None;None;IBM A   3 (-4.5A); ZN A   1 (-2.6A);None;IBM A   3 (-4.3A);None;IBM A   3 (-3.5A)","0.41A","1xoqA-3ecnA:44.9","1xoqA-3ecnA:33.42"],["1XOQ_A_ROFA502_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",3,"ASN A 729;TRP A 740;GLN A 778","None;None;IBM A   3 (-3.4A)","0.16A","1xoqA-3ecnA:44.9","1xoqA-3ecnA:33.42"],["1XOQ_B_ROFB501_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",8,"TYR A 555;HIS A 556;ASP A 726;PRO A 730;TRP A 740;ILE A 744;SER A 777;PHE A 781","None;None; ZN A   1 (-2.6A);None;None;IBM A   3 (-4.3A);None;IBM A   3 (-3.5A)","0.37A","1xoqB-3ecnA:45.0","1xoqB-3ecnA:33.42"],["1XOQ_B_ROFB501_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",3,"MET A 670;ASN A 729;GLN A 778","IBM A   3 (-4.5A);None;IBM A   3 (-3.4A)","0.34A","1xoqB-3ecnA:45.0","1xoqB-3ecnA:33.42"],["1XOS_A_VIAA1_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",6,"TYR A 555;HIS A 556;MET A 670;ASP A 726;GLN A 778;PHE A 781","None;None;IBM A   3 (-4.5A); ZN A   1 (-2.6A);IBM A   3 (-3.4A);IBM A   3 (-3.5A)","0.44A","1xosA-3ecnA:44.8","1xosA-3ecnA:34.16"],["1XOT_A_VDNA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",6,"TYR A 555;HIS A 556;ILE A 744;GLN A 778;PHE A 781;ILE A 786","None;None;IBM A   3 (-4.3A);IBM A   3 (-3.4A);IBM A   3 (-3.5A);None","1.31A","1xotA-3ecnA:44.8","1xotA-3ecnA:34.16"],["1XOT_A_VDNA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",7,"TYR A 555;HIS A 556;MET A 670;ILE A 744;SER A 777;GLN A 778;PHE A 781","None;None;IBM A   3 (-4.5A);IBM A   3 (-4.3A);None;IBM A   3 (-3.4A);IBM A   3 (-3.5A)","0.57A","1xotA-3ecnA:44.8","1xotA-3ecnA:34.16"],["1XOT_B_VDNB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",6,"TYR A 555;HIS A 556;ASN A 729;ILE A 744;SER A 777;PHE A 781","None;None;None;IBM A   3 (-4.3A);None;IBM A   3 (-3.5A)","0.60A","1xotB-3ecnA:44.7","1xotB-3ecnA:34.16"],["1XOT_B_VDNB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",7,"TYR A 555;HIS A 556;MET A 670;ASN A 729;ILE A 744;GLN A 778;PHE A 781","None;None;IBM A   3 (-4.5A);None;IBM A   3 (-4.3A);IBM A   3 (-3.4A);IBM A   3 (-3.5A)","0.40A","1xotB-3ecnA:44.7","1xotB-3ecnA:34.16"],["2DYR_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.30A","2dyrA-3ecnA:undetectable;2dyrC-3ecnA:undetectable","2dyrA-3ecnA:18.32;2dyrC-3ecnA:21.49"],["2DYR_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.32A","2dyrN-3ecnA:undetectable;2dyrP-3ecnA:undetectable","2dyrN-3ecnA:18.32;2dyrP-3ecnA:21.49"],["2DYS_C_CHDC304_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.29A","2dysA-3ecnA:undetectable;2dysC-3ecnA:undetectable","2dysA-3ecnA:18.32;2dysC-3ecnA:21.49"],["2DYS_P_CHDP304_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.29A","2dysN-3ecnA:undetectable;2dysP-3ecnA:undetectable","2dysN-3ecnA:18.32;2dysP-3ecnA:21.49"],["2EIJ_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.31A","2eijA-3ecnA:undetectable;2eijC-3ecnA:undetectable","2eijA-3ecnA:18.32;2eijC-3ecnA:21.49"],["2EIJ_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.32A","2eijN-3ecnA:undetectable;2eijP-3ecnA:undetectable","2eijN-3ecnA:18.32;2eijP-3ecnA:21.49"],["2EIK_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.32A","2eikA-3ecnA:undetectable;2eikC-3ecnA:undetectable","2eikA-3ecnA:18.32;2eikC-3ecnA:21.49"],["2EIK_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.34A","2eikN-3ecnA:undetectable;2eikP-3ecnA:undetectable","2eikN-3ecnA:18.32;2eikP-3ecnA:21.49"],["2EIL_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.31A","2eilA-3ecnA:undetectable;2eilC-3ecnA:undetectable","2eilA-3ecnA:18.32;2eilC-3ecnA:21.49"],["2EIL_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.32A","2eilN-3ecnA:undetectable;2eilP-3ecnA:undetectable","2eilN-3ecnA:18.32;2eilP-3ecnA:21.49"],["2EIM_A_CHDA525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.30A","2eimA-3ecnA:undetectable;2eimC-3ecnA:undetectable","2eimA-3ecnA:18.32;2eimC-3ecnA:21.49"],["2EIM_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.30A","2eimN-3ecnA:undetectable;2eimP-3ecnA:undetectable","2eimN-3ecnA:18.32;2eimP-3ecnA:21.49"],["2EIN_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.30A","2einA-3ecnA:undetectable;2einC-3ecnA:undetectable","2einA-3ecnA:18.32;2einC-3ecnA:21.49"],["2EIN_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.36A","2einN-3ecnA:undetectable;2einP-3ecnA:undetectable","2einN-3ecnA:18.32;2einP-3ecnA:21.49"],["2H42_A_VIAA901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",5,"TYR A 555;HIS A 556;ILE A 774;GLN A 778;PHE A 781","None;None;None;IBM A   3 (-3.4A);IBM A   3 (-3.5A)","0.37A","2h42A-3ecnA:35.0","2h42A-3ecnA:25.56"],["2H42_B_VIAB902_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",5,"TYR A 555;HIS A 556;ILE A 774;GLN A 778;PHE A 781","None;None;None;IBM A   3 (-3.4A);IBM A   3 (-3.5A)","0.46A","2h42B-3ecnA:34.8","2h42B-3ecnA:25.56"],["2WEY_A_EV1A1771_1","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",6,"TYR A 555;HIS A 556;ILE A 744;GLU A 747;GLN A 778;PHE A 781","None;None;IBM A   3 (-4.3A);None;IBM A   3 (-3.4A);IBM A   3 (-3.5A)","0.92A","2weyA-3ecnA:36.5","2weyA-3ecnA:24.68"],["2Y69_A_CHDA1517_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.31A","2y69A-3ecnA:undetectable;2y69C-3ecnA:undetectable","2y69A-3ecnA:18.32;2y69C-3ecnA:21.49"],["2ZXW_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.33A","2zxwA-3ecnA:undetectable;2zxwC-3ecnA:undetectable","2zxwA-3ecnA:18.32;2zxwC-3ecnA:21.49"],["2ZXW_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.32A","2zxwN-3ecnA:undetectable;2zxwP-3ecnA:undetectable","2zxwN-3ecnA:18.32;2zxwP-3ecnA:21.49"],["3ABK_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.33A","3abkA-3ecnA:undetectable;3abkC-3ecnA:undetectable","3abkA-3ecnA:18.32;3abkC-3ecnA:21.49"],["3ABK_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.31A","3abkN-3ecnA:undetectable;3abkP-3ecnA:undetectable","3abkN-3ecnA:18.32;3abkP-3ecnA:21.49"],["3ABM_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.30A","3abmN-3ecnA:undetectable;3abmP-3ecnA:undetectable","3abmN-3ecnA:18.32;3abmP-3ecnA:21.49"],["3AG1_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.36A","3ag1A-3ecnA:0.9;3ag1C-3ecnA:undetectable","3ag1A-3ecnA:18.32;3ag1C-3ecnA:21.49"],["3AG1_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.34A","3ag1N-3ecnA:undetectable;3ag1P-3ecnA:undetectable","3ag1N-3ecnA:18.32;3ag1P-3ecnA:21.49"],["3AG2_A_CHDA525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.33A","3ag2A-3ecnA:undetectable;3ag2C-3ecnA:undetectable","3ag2A-3ecnA:18.32;3ag2C-3ecnA:21.49"],["3AG2_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.34A","3ag2N-3ecnA:undetectable;3ag2P-3ecnA:undetectable","3ag2N-3ecnA:18.32;3ag2P-3ecnA:21.49"],["3AG3_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.31A","3ag3A-3ecnA:undetectable;3ag3C-3ecnA:undetectable","3ag3A-3ecnA:18.32;3ag3C-3ecnA:21.49"],["3AG3_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.32A","3ag3N-3ecnA:undetectable;3ag3P-3ecnA:undetectable","3ag3N-3ecnA:18.32;3ag3P-3ecnA:21.49"],["3AG4_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.33A","3ag4A-3ecnA:undetectable;3ag4C-3ecnA:undetectable","3ag4A-3ecnA:18.32;3ag4C-3ecnA:21.49"],["3AG4_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.33A","3ag4N-3ecnA:undetectable;3ag4P-3ecnA:undetectable","3ag4N-3ecnA:18.32;3ag4P-3ecnA:21.49"],["3ASN_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.32A","3asnA-3ecnA:undetectable;3asnC-3ecnA:undetectable","3asnA-3ecnA:18.32;3asnC-3ecnA:21.49"],["3B2R_A_VDNA1_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",5,"TYR A 555;HIS A 556;ILE A 774;GLN A 778;PHE A 781","None;None;None;IBM A   3 (-3.4A);IBM A   3 (-3.5A)","0.58A","3b2rA-3ecnA:30.5","3b2rA-3ecnA:25.27"],["3B2R_B_VDNB1_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",5,"TYR A 555;HIS A 556;ILE A 774;GLN A 778;PHE A 781","None;None;None;IBM A   3 (-3.4A);IBM A   3 (-3.5A)","0.55A","3b2rB-3ecnA:30.7","3b2rB-3ecnA:25.27"],["3G4L_A_ROFA901_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",5,"MET A 670;ASN A 729;PRO A 730;SER A 780;PHE A 781","IBM A   3 (-4.5A);None;None;None;IBM A   3 (-3.5A)","1.01A","3g4lA-3ecnA:44.8","3g4lA-3ecnA:32.98"],["3G4L_A_ROFA901_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",9,"TYR A 555;HIS A 556;MET A 670;ASN A 729;PRO A 730;TRP A 740;ILE A 744;SER A 777;PHE A 781","None;None;IBM A   3 (-4.5A);None;None;None;IBM A   3 (-4.3A);None;IBM A   3 (-3.5A)","0.43A","3g4lA-3ecnA:44.8","3g4lA-3ecnA:32.98"],["3G4L_B_ROFB902_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",8,"TYR A 555;HIS A 556;MET A 670;ASP A 726;PRO A 730;TRP A 740;ILE A 744;PHE A 781","None;None;IBM A   3 (-4.5A); ZN A   1 (-2.6A);None;None;IBM A   3 (-4.3A);IBM A   3 (-3.5A)","0.33A","3g4lB-3ecnA:44.8","3g4lB-3ecnA:32.98"],["3G4L_C_ROFC903_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",8,"TYR A 555;HIS A 556;MET A 670;ASP A 726;ASN A 729;PRO A 730;TRP A 740;ILE A 744","None;None;IBM A   3 (-4.5A); ZN A   1 (-2.6A);None;None;None;IBM A   3 (-4.3A)","0.31A","3g4lC-3ecnA:44.8","3g4lC-3ecnA:32.98"],["3G4L_C_ROFC903_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",3,"SER A 777;GLN A 778;PHE A 781","None;IBM A   3 (-3.4A);IBM A   3 (-3.5A)","0.22A","3g4lC-3ecnA:44.8","3g4lC-3ecnA:32.98"],["3G4L_D_ROFD904_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",9,"TYR A 555;HIS A 556;MET A 670;ASP A 726;PRO A 730;TRP A 740;ILE A 744;SER A 777;GLN A 778","None;None;IBM A   3 (-4.5A); ZN A   1 (-2.6A);None;None;IBM A   3 (-4.3A);None;IBM A   3 (-3.4A)","0.41A","3g4lD-3ecnA:44.7","3g4lD-3ecnA:32.98"],["3IAK_A_EV1A415_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",5,"TYR A 555;ILE A 744;GLN A 778;PHE A 781;ILE A 786","None;IBM A   3 (-4.3A);IBM A   3 (-3.4A);IBM A   3 (-3.5A);None","1.45A","3iakA-3ecnA:43.0","3iakA-3ecnA:33.42"],["3IAK_A_EV1A415_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",6,"TYR A 555;MET A 670;ASN A 729;ILE A 744;GLN A 778;PHE A 781","None;IBM A   3 (-4.5A);None;IBM A   3 (-4.3A);IBM A   3 (-3.4A);IBM A   3 (-3.5A)","0.53A","3iakA-3ecnA:43.0","3iakA-3ecnA:33.42"],["3JWQ_C_VIAC901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"TYR A 555;HIS A 556;GLN A 778;PHE A 781","None;None;IBM A   3 (-3.4A);IBM A   3 (-3.5A)","0.43A","3jwqC-3ecnA:37.9","3jwqC-3ecnA:26.10"],["3TVX_A_PNXA902_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",6,"TYR A 555;ASN A 729;PRO A 730;ILE A 744;GLN A 778;PHE A 781","None;None;None;IBM A   3 (-4.3A);IBM A   3 (-3.4A);IBM A   3 (-3.5A)","0.36A","3tvxA-3ecnA:44.3","3tvxA-3ecnA:34.09"],["3TVX_B_PNXB902_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4A","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",5,"TYR A 555;ASN A 729;ILE A 744;GLN A 778;PHE A 781","None;None;IBM A   3 (-4.3A);IBM A   3 (-3.4A);IBM A   3 (-3.5A)","0.38A","3tvxB-3ecnA:44.5","3tvxB-3ecnA:34.09"],["4UDA_A_DEXA1985_2","MINERALOCORTICOID RECEPTOR","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"LEU A 716;TRP A 793;LEU A 688;THR A 580","None","0.85A","4udaA-3ecnA:1.6","4udaA-3ecnA:21.65"],["5B1A_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.34A","5b1aN-3ecnA:undetectable;5b1aP-3ecnA:undetectable","5b1aN-3ecnA:18.32;5b1aP-3ecnA:21.49"],["5B1B_C_CHDC307_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;TYR A 619;HIS A 676;LEU A 608","None","1.19A","5b1bA-3ecnA:undetectable;5b1bC-3ecnA:undetectable;5b1bP-3ecnA:undetectable","5b1bA-3ecnA:18.32;5b1bC-3ecnA:21.49;5b1bP-3ecnA:21.49"],["5B1B_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.34A","5b1bN-3ecnA:undetectable;5b1bP-3ecnA:undetectable","5b1bN-3ecnA:18.32;5b1bP-3ecnA:21.49"],["5B3S_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.37A","5b3sN-3ecnA:undetectable;5b3sP-3ecnA:undetectable","5b3sN-3ecnA:18.32;5b3sP-3ecnA:21.49"],["5IY5_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.36A","5iy5A-3ecnA:undetectable;5iy5C-3ecnA:undetectable","5iy5A-3ecnA:18.32;5iy5C-3ecnA:21.49"],["5TZO_A_7V7A202_1","ENDO-1,4-BETA-XYLANASE A","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",5,"SER A 561;ALA A 592;PRO A 513;TRP A 541;ALA A 593","None","1.38A","5tzoA-3ecnA:undetectable","5tzoA-3ecnA:18.81"],["5TZO_C_7V7C201_1","ENDO-1,4-BETA-XYLANASE A","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",5,"SER A 561;ALA A 592;PRO A 513;TRP A 541;ALA A 593","None","1.37A","5tzoC-3ecnA:undetectable","5tzoC-3ecnA:18.81"],["5X19_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.36A","5x19N-3ecnA:undetectable;5x19P-3ecnA:undetectable","5x19N-3ecnA:18.32;5x19P-3ecnA:21.49"],["5X1B_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.36A","5x1bN-3ecnA:undetectable;5x1bP-3ecnA:undetectable","5x1bN-3ecnA:18.32;5x1bP-3ecnA:21.49"],["5X1F_P_CHDP305_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.41A","5x1fN-3ecnA:undetectable;5x1fP-3ecnA:1.6","5x1fN-3ecnA:18.32;5x1fP-3ecnA:21.49"],["5ZCQ_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.36A","5zcqN-3ecnA:undetectable;5zcqP-3ecnA:undetectable","5zcqN-3ecnA:18.32;5zcqP-3ecnA:21.49"],["6NKN_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.33A","6nknA-3ecnA:undetectable;6nknC-3ecnA:undetectable","6nknA-3ecnA:18.32;6nknC-3ecnA:21.49"],["6NMP_C_CHDC303_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.38A","6nmpA-3ecnA:0.7;6nmpC-3ecnA:undetectable","6nmpA-3ecnA:18.32;6nmpC-3ecnA:21.49"],["6NMP_P_CHDP302_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","3ecn","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","Homo sapiens",4,"ASP A 621;THR A 622;TYR A 619;HIS A 676","None","1.39A","6nmpN-3ecnA:undetectable;6nmpP-3ecnA:undetectable","6nmpN-3ecnA:18.32;6nmpP-3ecnA:21.49"]]